Creative Financial Designs’s VanEck Pharmaceutical ETF PPH Stock Holding History

Creative Financial Designs’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$169K	Sell	1,546 -340	-18%	-$35.2K	0.01%	645
2026 Q1	$196K	Hold	1,886	–	–	0.01%	523
2025 Q4	$195K	Buy	1,886 +11	+0.6%	+$1.07K	0.01%	478
2025 Q3	$169K	Sell	1,875 -254	-12%	-$22.2K	0.01%	510
2025 Q2	$187K	Buy	2,129 +327	+18%	+$28.3K	0.01%	506
2025 Q1	$164K	Buy	1,802 +1,294	+255%	+$117K	0.01%	498
2024 Q4	$43.8K	Buy	508 +2	+0.4%	+$181	﹤0.01%	824
2024 Q3	$48K	Buy	506 +81	+19%	+$7.69K	﹤0.01%	782
2024 Q2	$38.9K	Buy	+425	New	+$37.9K	﹤0.01%	817

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Creative Financial Designs's PPH Position: Q2 2026 in Review

Creative Financial Designs reduced its VanEck Pharmaceutical ETF (PPH) stake by 18% in Q2 2026, selling an estimated $35.2K and leaving 1,546 shares worth $169K. The position accounts for 0.01% of the portfolio, ranked #645.

Creative Financial Designs first reported a position in PPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $196K in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Creative Financial Designs held 1,546 shares of VanEck Pharmaceutical ETF worth $169K as of Q2 2026.
Creative Financial Designs sold 340 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $35.2K.
VanEck Pharmaceutical ETF made up 0.01% of Creative Financial Designs's portfolio in Q2 2026, its #645 holding.
Creative Financial Designs first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 9 quarters since.
Creative Financial Designs's VanEck Pharmaceutical ETF position peaked at $196K in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.